Table 1 Patient characteristics
Parameter | UCB-haplo group (n, percent %) | Haplo group (n, percent %) |
|---|---|---|
Age at HSCT, years | Â | Â |
 < 20 | 15/53 (28.30%) | 9/26 (34.62%) |
 20–40 | 27/53 (50.94%) | 11/26 (42.31%) |
 > 40 | 11/53 (20.75%) | 6/26 (23.08%) |
Gender | Â | Â |
 Male | 27/53 (50.94%) | 14/26 (53.85%) |
 Female | 26/53 (49.06%) | 12/26 (46.15%) |
Disease diagnosis | Â | Â |
 AA | 15/53 (28.30%) | 4/26 (15.38%) |
 MDS | 11/53 (20.75%) | 6/26 (23.08%) |
 AML | 15/53 (28.30%) | 9/26 (34.62%) |
 ALL | 9/53 (16.98%) | 5/26 (19.23%) |
 Others | 3/53 (5.66%) | 2/26 (7.69%) |
Disease status | Â | Â |
 CR1 | 18/53 (33.96%) | 7/26 (26.92%) |
 CR2 | 2/53 (3.77%) | 2/26 (7.69%) |
 MRD positive | 2/53 (3.77%) | 1/26 (3.85%) |
 PR | 0/53 (0.00%) | 5/26 (19.23%) |
 NR | 16/53 (30.19%) | 7/26 (26.92%) |
Donor recipient relationship | Â | Â |
 Female-male | 4/53 (7.55%) | 4/26 (15.38%) |
 Second-degree donor | 4/53 (7.55%) | 0/26 (0.00%) |
 Others | 45/53 (84.90%) | 22/26 (84.62%) |
Mismatched HLA | Â | Â |
 3 loci | 34/53 (64.15%) | 13/26 (50.00%) |
 2 loci | 9/53 (16.98%) | 5/26 (19.23%) |
 0–1 locus | 10/53 (18.87%) | 8/26 (30.77%) |
ABO match | Â | Â |
 Matched | 29/53 (54.72%) | 13/26 (50.00%) |
 Minor mismatched | 10/53 (18.87%) | 4/26 (15.38%) |
 Major mismatched | 10/53 (18.86%) | 7/26 (26.92%) |
 Major and minor mismatched | 4/53 (7.55%) | 2/26 (7.69%) |
EBMT risk score | Â | Â |
 0–1 point | 17/53 (32.08%) | 4/26 (15.38%) |
 2–3 points | 19/53 (35.85%) | 9/26 (34.62%) |
 4–6 points | 17/53 (32.08%) | 13/26 (50.00%) |